In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes

Thumbnail
Ver/Abrir
Use este enlace para citar
http://hdl.handle.net/2183/41799
Creative Commons Attribution 4.0 International License (CC-BY 4.0)
Excepto si se señala otra cosa, la licencia del ítem se describe como Creative Commons Attribution 4.0 International License (CC-BY 4.0)
Colecciones
Metadatos
Mostrar el registro completo del ítem
Título
In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes
Autor(es)
Fecha
2024-11-06
Cita bibliográfica
Rodríguez-Pallares S, Blanco-Martín T, Lence E, Aja-Macaya P, Sánchez-Peña L, González-Pinto L, Rodríguez-Mayo M, Fernández-González A, Galán-Sánchez F, Beceiro A, González-Bello C, Bou G, Arca-Suárez J. In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes. Antimicrob Agents Chemother. 2024 Dec 5;68(12):e0130724.
Resumen
[Abstract] We describe the in vivo emergence of resistance to ceftazidime/avibactam via modification of AmpC in a clinical Klebsiella aerogenes isolate during therapy with this combination. Paired ceftazidime/avibactam-susceptible/resistant isolates were obtained before and during ceftazidime/avibactam treatment. Whole genome sequencing revealed a differential mutation in AmpC (R148W) in the ceftazidime/avibactam-resistant isolate. Molecular cloning and structural studies confirmed the impact of this substitution, which affects the architecture of the H10 helix, on the evolved resistant phenotype.
Palabras clave
AmpC
Klebsiella aerogenes
Ceftazidime/avibactam
Evolution
β-lactamase
 
Descripción
Brief report
Versión del editor
Derechos
Creative Commons Attribution 4.0 International License (CC-BY 4.0)
ISSN
0066-4804